Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
RECURSION PHARMACEUTICALS, INC. (RXRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 59,794 shares
@ $7.2085, valued at
$431k
Exercised 31,250 options to buy
@ $2.48, valued at
$77.5k
|
|
| 10/05/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $7.2907, valued at
$64.8k
|
|
| 10/04/2023 |
4
| Dar Zavain (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,920 shares
@ $0 |
|
| 10/04/2023 |
4
| CHAVEZ R. MARTIN (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 2,619 shares
@ $0 |
|
| 10/04/2023 |
4
| Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,659 shares
@ $0
Gifted 627,705 shares
@ $0 |
|
| 10/02/2023 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 3,000 shares
@ $7.7198, valued at
$23.2k
Exercised 3,000 options to buy
@ $1.06, valued at
$3.2k
|
|
| 08/24/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $8.9118, valued at
$79.2k
|
|
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Converted 10,000 shares
@ $0
Gifted 10,000 shares
@ $0
Converted 10,000 options to buy
@ $0 |
|
| 08/10/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 14,498 shares
@ $11.0255, valued at
$159.8k
Sold 3,272 shares
@ $11.7468, valued at
$38.4k
|
|
| 08/04/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 60,955 shares
@ $13.0171, valued at
$793.5k
Sold 4,060 shares
@ $13.3631, valued at
$54.3k
Exercised 8,674 options to buy
@ $11.4, valued at
$98.9k
Exercised 31,250 options to buy
@ $2.48, valued at
$77.5k
|
|
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2023 |
4
| Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 20,000 shares
@ $14.3, valued at
$286k
Sold 20,000 shares
@ $14.41, valued at
$288.2k
Exercised 20,000 options to buy
@ $2.22, valued at
$44.4k
Exercised 20,000 options to buy
@ $2.22, valued at
$44.4k
|
|
| 07/27/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Gifted 14,000 shares
@ $0
Sold 18,719 shares
@ $14.6089, valued at
$273.5k
|
|
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $6.8873, valued at
$61.2k
|
|
| 07/06/2023 |
4
| Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,609 shares
@ $0 |
|
| 07/06/2023 |
4
| Dar Zavain (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,863 shares
@ $0 |
|
| 07/06/2023 |
4
| CHAVEZ R. MARTIN (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 2,541 shares
@ $0 |
|
| 07/06/2023 |
4
| Bogue Zachary (10% Owner) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,440 shares
@ $0 |
|
| 07/03/2023 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 3,000 shares
@ $7.49, valued at
$22.5k
Exercised 3,000 options to buy
@ $1.06, valued at
$3.2k
|
|
| 06/29/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $7.3876, valued at
$65.6k
|
|
| 06/16/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Converted 10,000 shares
@ $0
Gifted 10,000 shares
@ $0
Converted 10,000 options to buy
@ $0 |
|
| 06/15/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 15,485 shares
@ $9.9778, valued at
$154.5k
|
|
| 06/15/2023 |
4
| Secora Michael (CFO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 25,000 shares
@ $9.9323, valued at
$248.3k
Sold 25,000 shares
@ $10.0735, valued at
$251.8k
Exercised 37,500 options to buy
@ $2.22, valued at
$83.3k
Exercised 37,500 options to buy
@ $2.22, valued at
$83.3k
|
|
| 06/09/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 56,436 shares
@ $9.0511, valued at
$510.8k
Exercised 31,250 options to buy
@ $2.48, valued at
$77.5k
|
|
|
|
|